These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18205806)

  • 1. Staphylococcus aureus infection triggers production of neutralizing, V8 protease-specific antibodies.
    Calander AM; Dubin G; Potempa J; Tarkowski A
    FEMS Immunol Med Microbiol; 2008 Mar; 52(2):267-72. PubMed ID: 18205806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of specific immunoglobulin production in SCID-hu-PBL mice after in vitro priming of human B cells with superantigen.
    Mårtensson C; Ifversen P; Borrebaeck CA; Carlsson R
    Immunology; 1995 Oct; 86(2):224-30. PubMed ID: 7490122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial cell wall-expressed protein A triggers supraclonal B-cell responses upon in vivo infection with Staphylococcus aureus.
    Palmqvist N; Silverman GJ; Josefsson E; Tarkowski A
    Microbes Infect; 2005 Dec; 7(15):1501-11. PubMed ID: 16039897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyclonal B-cell activation by an arthritogenic Staphylococcus aureus strain: contribution of T-cells and monokines.
    Abdelnour A; Tarkowski A
    Cell Immunol; 1993 Apr; 147(2):279-93. PubMed ID: 8453672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-staphylococcal humoral immune response in persistent nasal carriers and noncarriers of Staphylococcus aureus.
    Verkaik NJ; de Vogel CP; Boelens HA; Grumann D; Hoogenboezem T; Vink C; Hooijkaas H; Foster TJ; Verbrugh HA; van Belkum A; van Wamel WJ
    J Infect Dis; 2009 Mar; 199(5):625-32. PubMed ID: 19199541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with glutathione S-transferase and mutant toxic shock syndrome toxin 1 fusion protein protects against Staphylococcus aureus infection.
    Cui JC; Hu DL; Lin YC; Qian AD; Nakane A
    FEMS Immunol Med Microbiol; 2005 Jul; 45(1):45-51. PubMed ID: 15985222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multiplex assay for the quantification of antibody responses in Staphylococcus aureus infections in mice.
    van den Berg S; Bowden MG; Bosma T; Buist G; van Dijl JM; van Wamel WJ; de Vogel CP; van Belkum A; Bakker-Woudenberg IA
    J Immunol Methods; 2011 Feb; 365(1-2):142-8. PubMed ID: 21185300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of serum IgM antibodies against superantigens of Staphylococcus aureus and Streptococcus pyogenes in Kawasaki disease.
    Matsubara K; Fukaya T; Miwa K; Shibayama N; Nigami H; Harigaya H; Nozaki H; Hirata T; Baba K; Suzuki T; Ishiguro A
    Clin Exp Immunol; 2006 Mar; 143(3):427-34. PubMed ID: 16487241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of genes encoding extracellular proteases in Staphylococcus aureus - important targets triggering immune response in vivo.
    Zdzalik M; Karim AY; Wolski K; Buda P; Wojcik K; Brueggemann S; Wojciechowski P; Eick S; Calander AM; Jonsson IM; Kubica M; Polakowska K; Miedzobrodzki J; Wladyka B; Potempa J; Dubin G
    FEMS Immunol Med Microbiol; 2012 Nov; 66(2):220-9. PubMed ID: 22762789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination with nontoxic mutant toxic shock syndrome toxin 1 protects against Staphylococcus aureus infection.
    Hu DL; Omoe K; Sasaki S; Sashinami H; Sakuraba H; Yokomizo Y; Shinagawa K; Nakane A
    J Infect Dis; 2003 Sep; 188(5):743-52. PubMed ID: 12934191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous and pokeweed mitogen-induced in vitro IgG production specific for S. aureus cell wall determinants in man.
    Hauser C; Wilhelm JA; Matter L; Schopfer K
    Clin Exp Immunol; 1984 Jul; 57(1):227-33. PubMed ID: 6204800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staphylococcus aureus carriers neutralize superantigens by antibodies specific for their colonizing strain: a potential explanation for their improved prognosis in severe sepsis.
    Holtfreter S; Roschack K; Eichler P; Eske K; Holtfreter B; Kohler C; Engelmann S; Hecker M; Greinacher A; Broker BM
    J Infect Dis; 2006 May; 193(9):1275-8. PubMed ID: 16586365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coordinated and differential control of aureolysin (aur) and serine protease (sspA) transcription in Staphylococcus aureus by sarA, rot and agr (RNAIII).
    Oscarsson J; Tegmark-Wisell K; Arvidson S
    Int J Med Microbiol; 2006 Oct; 296(6):365-80. PubMed ID: 16782403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered immune response to staphylococcal antigens in long-lasting implanted mice.
    Sadowska B; Zoładek J; Ljungh A; Rudnicka W; Rózalska B
    Acta Microbiol Pol; 1997; 46(3):253-61. PubMed ID: 9429295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of gamma interferon in acquired host resistance against Staphylococcus aureus infection in mice.
    Sasaki S; Tagawa Y; Iwakura Y; Nakane A
    FEMS Immunol Med Microbiol; 2006 Apr; 46(3):367-74. PubMed ID: 16553809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal immunization of mutant toxic shock syndrome toxin 1 elicits systemic and mucosal immune response against Staphylococcus aureus infection.
    Narita K; Hu DL; Tsuji T; Nakane A
    FEMS Immunol Med Microbiol; 2008 Apr; 52(3):389-96. PubMed ID: 18312579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Broad-spectrum immunity against superantigens is elicited in mice protected from lethal shock by a superantigen antagonist peptide.
    Arad G; Hillman D; Levy R; Kaempfer R
    Immunol Lett; 2004 Feb; 91(2-3):141-5. PubMed ID: 15019282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neutralizing effects of hyperimmune antibodies against extracellular fibrinogen-binding protein, Efb, from Staphylococcus aureus.
    Shannon O; Uekotter A; Flock JI
    Scand J Immunol; 2006 Mar; 63(3):184-90. PubMed ID: 16499571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody response to the extracellular adherence protein (Eap) of Staphylococcus aureus in healthy and infected individuals.
    Joost I; Jacob S; Utermöhlen O; Schubert U; Patti JM; Ong MF; Gross J; Justinger C; Renno JH; Preissner KT; Bischoff M; Herrmann M
    FEMS Immunol Med Microbiol; 2011 Jun; 62(1):23-31. PubMed ID: 21251089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of B cell response during Yersinia enterocolitica infection in resistant and susceptible strains of mice.
    Cangiani EE; Guiraldi FR; Pinto SE; de Medeiros BM
    Immunol Invest; 2007; 36(4):387-402. PubMed ID: 17691021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.